CRSP

Q: What is the price of CRISPR Therapeutics (CRSP) today?

The price of CRISPR Therapeutics (CRSP) today is R$ 297,45, with a variation of 11.61% compared to the last year. The price of CRISPR Therapeutics (CRSP) started the year trading around R$ 213,33 and today it is at R$ 297,45. Follow the real-time price chart, the historical price of CRISPR Therapeutics (CRSP), and stock data from Ibovespa and international markets.

Q: When does CRISPR Therapeutics (CRSP) pay dividends?

CRISPR Therapeutics (CRSP) did not distribute dividends in the last year.

Q: CRISPR Therapeutics (CRSP) is it worth it?

Currently, CRISPR Therapeutics (CRSP) is priced at R$ 297,45, with a P/E of -10,10%, representing a deviation of -8,26% from its historical average P/E. In the last year, the stock showed a variation of 11.61% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 11,61%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of CRISPR Therapeutics (CRSP)?

Investing in shares of CRISPR Therapeutics (CRSP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of CRISPR Therapeutics (CRSP) yield today?

The yield of CRISPR Therapeutics (CRSP) was -15,26% in the last month, 11,61% in the last year and -39,50% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of CRISPR Therapeutics (CRSP) today, the total investment would be based on the current price of R$ 297,45.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 33.198,35In 5 years: R$ 17.995,70In 10 years: 29.744,96It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CRISPR Therapeutics AG

Price

US$ 54,88

variation (12m)

11,61%

p/l

-10,10

p/vp

2,76

DIVIDEND YIELD

0,00%

quote CRSP

BVMF

CRSP

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of CRSP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-15,26%

3 months

47,43%

1 year

11,61%

2 years

9,85%

5 years

-39,50%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-15,26%

3 months

46,70%

1 year

6,05%

2 years

0,13%

5 years

-55,79%

10 years

0,00%

Indicators CRSP

check out the fundamentals of CRISPR Therapeutics shares

P/L

-10,10

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

135,02

Sector: -3,77 Industry: -3,77

P/VP

2,76

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-23,05%

Sector: -63,50% Industry: -63,50%

ROE

-27,34%

Sector: -67,23% Industry: -67,23%

ROIC

-290,60%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

-100,00%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

-100,00%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

-100,00%

Sector: -43,21% Industry: -43,21%

P/EBITDA

-8,86

Sector: -3,13 Industry: -3,13

P/EBIT

-8,55

Sector: -3,41 Industry: -3,41

P/ASSETS

2,33

Sector: 1,29 Industry: 1,29

VPA

19,67

Sector: 1,80 Industry: 1,80

LPA

-5,38

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,84

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

117,50%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

6,04%

Sector: - Industry: -

CRSP indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%
HRMY	11,93	2,79	23,40%	0,00%	US$ 2,16 B	23,42%

comparison of CRSP with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history CRSP dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

Average user rating I10

4.0 (9 people)

Estados Unidos

12 years

Foundation: 2013

2016

Year of debut on the stock exchange - 9 years

93

Employees

The Company CRISPR Therapeutics AG (Estados Unidos), is listed on Nasdaq with a market value of $ 4,73 Billions, having a net worth of $ 1,71 Billion.

With a total of 93 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 35,00 Milhões, which generated a loss in the amount of $ -467,80 Milhões.

As for its main indicators, the Company has a P/E ratio of -10,10, a P/B ratio of 2,76 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker CRSP.

Market value

US$ 4,73 Billions

Net worth

US$ 1,71 Billion

US$ 1.711.120.000,00

Assets

US$ 2,03 Billions

US$ 2.029.710.000,00

Total Number of Shares

87,00 Milhões

87.000.000

Average Daily Trading Volume

US$ 3,53 Milhões

US$ 3.525.130,88

Sector

Cuidados de saúde

Industry

Biotecnologia

CRSP

CRSP revenue and profits

CRSP results

DRAG THE FRAME TO SEE MORE DATA

CRSP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of CRISPR Therapeutics (CRSP) today?

The price of CRISPR Therapeutics (CRSP) today is R$ 297,45, with a variation of 11.61% compared to the last year. The price of CRISPR Therapeutics (CRSP) started the year trading around R$ 213,33 and today it is at R$ 297,45. Follow the real-time price chart, the historical price of CRISPR Therapeutics (CRSP), and stock data from Ibovespa and international markets.

When does CRISPR Therapeutics (CRSP) pay dividends?

CRISPR Therapeutics (CRSP) did not distribute dividends in the last year.

CRISPR Therapeutics (CRSP) is it worth it?

Currently, CRISPR Therapeutics (CRSP) is priced at R$ 297,45, with a P/E of -10,10%, representing a deviation of -8,26% from its historical average P/E. In the last year, the stock showed a variation of 11.61% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 11,61%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of CRISPR Therapeutics (CRSP)?

Investing in shares of CRISPR Therapeutics (CRSP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of CRISPR Therapeutics (CRSP) yield today?

The yield of CRISPR Therapeutics (CRSP) was -15,26% in the last month, 11,61% in the last year and -39,50% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of CRISPR Therapeutics (CRSP) today, the total investment would be based on the current price of R$ 297,45.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 33.198,35
In 5 years: R$ 17.995,70
In 10 years: 29.744,96

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

CRSP

CRISPR Therapeutics AG

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of CRSP

check out the fundamentals of CRISPR Therapeutics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY CRISPR Therapeutics

CRISPR Therapeutics AG

Estados Unidos

12 years

2016

93

PROFIT X PRICE CRSP

CRSP results

CRSP cash flow

evolution of assets - CRSP

CRSP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80